HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lattice corneal dystrophy type 1 in a Canadian kindred is associated with the Arg124 --> Cys mutation in the kerato-epithelin gene. [email protected].

AbstractPURPOSE:
To identify the mutation responsible for lattice corneal dystrophy type 1 in an extended Canadian kindred.
METHODS:
A search for a mutation in the candidate gene, kerato-epithelin, was carried out by single-strand conformation polymorphism and sequencing analyses.
RESULTS:
AC --> T mutation at position 417 was detected in exon 4 of the kerato-epithelin gene, which is expected to cause an Arg124 --> Cys change. This is the same nucleotide change described previously in two Swiss families with lattice corneal dystrophy type 1.
CONCLUSION:
Although the possibility that the three families (two previously described Swiss families and this Canadian kindred) are related has not been excluded, it appears that the unique phenotype of lattice corneal dystrophy type 1 is caused by this particular amino acid change.
AuthorsS K Gupta, W G Hodge, K F Damji, D L Guernsey, P E Neumann
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 125 Issue 4 Pg. 547-9 (Apr 1998) ISSN: 0002-9394 [Print] United States
PMID9559741 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Extracellular Matrix Proteins
  • Neoplasm Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein
  • DNA
  • Arginine
  • Cysteine
Topics
  • Arginine (genetics)
  • Canada
  • Chromosomes, Human, Pair 5 (genetics)
  • Corneal Dystrophies, Hereditary (genetics)
  • Cysteine (genetics)
  • DNA (analysis)
  • DNA Primers (chemistry)
  • Extracellular Matrix Proteins
  • Female
  • Humans
  • Male
  • Neoplasm Proteins (genetics)
  • Pedigree
  • Point Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational
  • Transforming Growth Factor beta (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: